Hjerte-magnetisk resonans (HMR) er en stråle-fri scanningsteknik, der giver den bedste standard til evaluering af hjertets anatomi, funktion og endda vævssammensætning. I RESILIENCE-forsøget anvendes HMR som den primære metode, og patienter vil i forsøgspersioden modtage 3 af disse scanninger.
RESILIENCE-forsøget er et multinationalt, prospektivt, proof-of-concept fase II, dobbeltblindet, sham-kontrolleret, randomiseret klinisk forsøg (RCT) til at evaluere effekten og sikkerheden af fjern iskæmisk prækonditionering (RIC) hos patienter med Lymfom der modtager kræftbehandling med antracykliner. Forsøgsdeltagelse forudsætter ≥5 planlagte kemoterapibehandlinger.
A new center joins the RESILIENCE project. It is the hospital La Paz in Madrid, awarded several times as the best public hospital in Spain, which welcomed us with open arms and with which we are looking forward to collaborate. We started the year 2023 more committed than ever to
The new Clinical Practice Guidelines of Cardio-Oncology were released in August 2022. RESILIENCE is proud to count with two relevant members of the Task Force as project investigators. Teresa López-Fernández is the Chairperson of this Clinical Practice Guideline and co-Principal investigator of European Society of Cardiology (ESC) in RESILIENCE project.
We have had the opportunity to talk about resilience with two great figures of Spanish sports, Almudena Cid and Julio García Mera. They have shared with us how resilience has allowed them to face the most difficult moments of their sports careers and how they have transferred that resilience to
On Thursday, November 17th we participated in the XXII Week of Science and Innovation in Madrid with our activity “Visit to a CNIC laboratory to learn about the use of technology and its innovative aspects in the RESILIENCE project”. More than 60 people of different ages, students and professionals from
On November 2nd, RESILIENCE team traveled to Portugal to visit the two medical centers that have just joined our RESILIENCE project, Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E. (IPO) and Hospital Da Luz. Both hospitals will collaborate in the growth of our project in the Portuguese country; IPO
We are glad to announce that in October 13th new centers have joined the RESILIENCE project, welcome to our team to Hospital Clínico Universitario de Valladolid! This is great news as during the summer 2022 three new sites have also been opened: • Hospital Universitario de Salamanca, July 22nd. •
RESILIENCE-forsøget er et multinationalt, prospektivt, proof-of-concept fase II, dobbeltblindet, sham-kontrolleret, randomiseret klinisk forsøg (RCT) til at evaluere effekten og sikkerheden af fjern iskæmisk prækonditionering .
